Trial Profile
EVALUATION OF THE EFFICACY OF TOLCAPONE AS A GENOTYPE-BASED TARGETED COGNITIVE ENHANCER IN SCHIZOPHRENIA, BASED ON THE POLYMORPHISM RS4680.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2020
Price :
$35
*
At a glance
- Drugs Tolcapone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 08 Jul 2014 New trial record